Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract

ABSTRACT Objective Currently, chimeric antigen receptor T‐cell (CART) therapy represents a highly effective approach for relapsed/refractory B‐cell lymphomas. However, it also carries treatment‐related risks. Limited data are available on the risks associated with CART therapy in patients with gastr...

Full description

Saved in:
Bibliographic Details
Main Authors: Lixia Ma, Yimeng Dou, Rui Liu, Teng Xu, Fan Yang, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui Shi, Fei Xue, Biping Deng, Xiaoyan Ke, Kai Hu
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.70083
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items